not tagged
abbvie,genmab
['lymphoma', '$gmab', '$abbv', 'abbvie']
abbvie, genmab bispecific shows cr rate of at least 34% in lymphoma trial $abbv $gmab #eha22 
The latest global #pharma news, insights, analysis, and views providing you with an information edge.  FirstWord Pharma. Where people who know first, go first.